MSR50 Comparing Survival Extrapolation Outcomes Using Different Network Meta-Analyses (NMA) Methods: An Application in Patients With Metastatic Renal Cell Carcinoma (MRCC) Treated With Immunotherapy (IO) Based Combinations
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1781
https://www.valueinhealthjournal.com/article/S1098-3015(22)03986-9/fulltext
Title :
MSR50 Comparing Survival Extrapolation Outcomes Using Different Network Meta-Analyses (NMA) Methods: An Application in Patients With Metastatic Renal Cell Carcinoma (MRCC) Treated With Immunotherapy (IO) Based Combinations
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03986-9&doi=10.1016/j.jval.2022.09.1781
First page :
Section Title :
Open access? :
No
Section Order :
11331